When the Complex Meets the High-Risk: Mechanical Cardiac Support Devices and Percutaneous Coronary Interventions in

Hung Q Ly1, Pierre-Emmanuel Noly2, Mohamed Nosair1

  • 1Interventional Cardiology Service, Department of Medicine, Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada.

Insights

Identifying patients with coronary artery disease (CAD) needing mechanical support during high-risk percutaneous coronary intervention (PCI) is challenging. A heart-team approach optimizes care for these complex cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Coronary artery disease (CAD) is a major global health concern, leading to significant mortality and morbidity.
  • Existing practice guidelines offer limited direct recommendations for revascularization in high-risk CAD patients.
  • Identifying patients requiring mechanical cardiocirculatory support devices (MCSDs) during high-risk percutaneous coronary intervention (HR-PCI) presents a clinical challenge.

Purpose of the Study:

  • To review the evolving concept of protected percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD).
  • To discuss the critical role of mechanical cardiocirculatory support devices (MCSDs) in high-risk PCI (HR-PCI).
  • To emphasize the importance of a balanced, integrated heart-team approach for optimal patient-centered care in HR-PCI with MCSD.

Main Methods:

  • Literature review focusing on protected PCI strategies.
  • Analysis of factors influencing the decision for MCSD use in HR-PCI.
  • Discussion of the heart-team approach in managing complex CAD patients undergoing HR-PCI.

Main Results:

  • The complexity of coronary anatomy and comorbidities significantly impacts risk assessment in HR-PCI.
  • Hemodynamic status is a crucial determinant for considering MCSD use during HR-PCI.
  • Protected PCI, supported by MCSDs, offers a viable strategy for select high-risk CAD patients.

Conclusions:

  • A multidisciplinary heart-team approach is essential for optimizing patient selection and management in HR-PCI.
  • The integration of MCSDs represents a key advancement in managing high-risk patients undergoing PCI.
  • Personalized, patient-centered care is paramount when considering revascularization in complex CAD cases requiring MCSD support.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
252
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
373
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
199
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
187